Ditto Bio develops AI-driven therapeutics by harnessing parasite biology to treat autoimmune diseases effectively.
Ditto Bio's investors include Y Combinator, Pioneer Fund.
Ditto Bio is headquartered in San Francisco, United States.
Ditto Bio develops AI-driven therapeutics by harnessing parasite biology to treat autoimmune diseases effectively.
Ditto Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ditto Bio — Funding & Investors." VCBacked, February 9, 2026, https://www.vcbacked.co/company/ditto-bio. Accessed September 2, 2026.
VCBacked. (2026). Ditto Bio — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/ditto-bio
{{cite web |title=Ditto Bio — Funding & Investors |url=https://www.vcbacked.co/company/ditto-bio |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated